Administration of MMR, Varicella, and Tdap Vaccines Together

Route of Administration

The Centers for Disease Control and Prevention recommends administering MMR and Varicella vaccines subcutaneously and Tdap vaccine intramuscularly, using separate syringes at different anatomic sites 1, 2
The MMR vaccine should be administered subcutaneously in a 0.5 mL dose, as recommended by the FDA 1, 2
The Varicella vaccine should also be administered subcutaneously in a 0.5 mL dose, using a separate syringe and different anatomic site from MMR 1, 2
The Tdap vaccine should be administered intramuscularly, which is the standard route for all tetanus-containing vaccines 3

The Advisory Committee on Immunization Practices (ACIP) recommends giving all three vaccines at the same visit, as there is no medical reason to separate these vaccines 1, 2, 4
The ACIP explicitly encourages routine simultaneous administration of MMR with other vaccines, including DTaP, without any adverse impact on immunogenicity or safety 1, 2

Antibody responses are equivalent whether vaccines are given simultaneously or separated by weeks, as shown in studies 1, 2
No clinically significant increases in adverse events occur with simultaneous administration, according to the ACIP 1, 2
MMR and varicella vaccines given simultaneously produce identical seroconversion rates and antibody levels compared to vaccines given 6 weeks apart, as recommended by the ACIP 1, 2
Inactivated vaccines like Tdap do not interfere with live vaccines like MMR and varicella, as stated by the CDC 3, 4

If MMR and Varicella vaccines cannot be given simultaneously, a minimum of 4 weeks should be waited before administering the second live vaccine, as recommended by the CDC 3
No spacing is required between inactivated vaccines (Tdap) and live vaccines (MMR, Varicella), according to the CDC 3, 4
Tdap can be given at any interval before or after MMR and Varicella without affecting immunogenicity, as stated by the CDC 3

Administering all three vaccines together increases vaccination coverage by reducing missed opportunities, as recommended by the ACIP 4, 5
Simultaneous administration reduces clinic visits required, improving patient compliance, according to the CDC 4, 5
It provides timely protection against all diseases without delay, as stated by the CDC 5
Simultaneous administration is critical when uncertain whether the patient will return for future doses, as recommended by the ACIP 5

Delaying any vaccine unnecessarily should be avoided, as there is no benefit to spacing these vaccines apart, according to the CDC 1, 2, 4
Confusing the live-to-live vaccine spacing rule with inactivated-to-live vaccine administration should be avoided, as Tdap requires no spacing from MMR or Varicella, as stated by the CDC 3, 4
Reduced volumes should not be used, and the full 0.5 mL dose of each vaccine should be administered, as recommended by the FDA 1, 2
Vaccines should not be mixed in the same syringe unless specifically FDA-approved, according to the CDC 6
The wrong route of administration should be avoided, as MMR and Varicella are subcutaneous, not intramuscular in standard U.S. practice, as recommended by the FDA 1, 2

Multiple large studies demonstrate that simultaneous administration of MMR, Varicella, and pertussis-containing vaccines (DTaP/Tdap) is safe, according to the CDC 1, 2
Serious adverse events are not increased with simultaneous administration, as stated by the ACIP 1, 2

The CDC’s Advisory Committee on Immunization Practices (ACIP) specifies that the measles‑mumps‑rubella (MMR) vaccine should be given as a 0.5 mL dose subcutaneously. 7
The varicella vaccine should be administered as a 0.5 mL dose subcutaneously at a different anatomic site from the MMR injection. 7
The tetanus, diphtheria, and pertussis (Tdap) vaccine should be given as a 0.5 mL dose intramuscularly. 7
The inactivated polio vaccine (IPV) may be administered as a 0.5 mL dose either intramuscularly or subcutaneously. 7

When the MMR and varicella vaccines are administered on the same day, no interval spacing is required between them. [8][7]
If the MMR and varicella vaccines are not given on the same day, they must be separated by at least 28 days (4 weeks) to avoid reduced immunogenicity. [8][7]